Profile_bird

Hey there! FDA_Drug_Info is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving FDA_Drug_Info's tweets.

Already using Twitter
from your phone? Click here.

FDA_Drug_Info

  1. FDA’s Woodcock Discusses Pain Management & Drug Safety in new Issue of New England Journal of Med. http://bit.ly/JW_PM
  2. Early Communication about an Ongoing Safety Review of Meridia (sibutramine hydrochloride). http://bit.ly/Meridia
  3. Info for Healthcare Professionals - Peramivir IV Renal Dosing Recommendations. http://bit.ly/PV_RD
  4. FDA's Drug Safety Oversight Board met today to discuss the clopidogrel-omeprazole interaction. Public summary in a few weeks
  5. FDA posts public summary for October 17th Drug Safety Oversight Board meeting. http://bit.ly/OctDSB
  6. FDA Issues 22 Warning Letters to Web site Operators. http://bit.ly/WebWarnL
  7. FDA Approves New Drug Qutenza (capsaicin) for Long-Term Pain Relief after Shingles Attacks. http://bit.ly/Qutenza
  8. Updated Safety Info about Drug Interaction Between Clopidogrel (Plavix) and Omeprazole (Prilosec, Prilosec OTC). http://bit.ly/PlavPril
  9. FDA Approves Lysteda (tranexamic acid) to Treat Heavy Menstrual Bleeding. http://bit.ly/Lysteda
  10. Q&A for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV. http://bit.ly/P_IV
  11. Info for Healthcare Professionals: Chondrolysis Reported with Continuously Infused Local Anesthetics. http://bit.ly/Chon_LA
  12. Info for Healthcare Professionals: Potential Contamination of Cerezyme, Fabrazyme, Myozyme, Aldurazyme, Thyrogen. http://bit.ly/G_Z
  13. Webcast of Public Hearing on Promotion of FDA-Regulated Products Using the Internet and Social Media Tools,http://bit.ly/8L3cW
  14. RT@CDC_eHealth Get the latest CDC info on H1N1 flu & more delivered to your cell phone. Text Health to 87000. More info http://is.gd/41mdl
  15. romidepsin(ISTODAX), Approved to treat cutaneous T-cell lymph. in patients who have received at least 1 prior therapy.http://bit.ly/ISTODAX
  16. Updated Emergency Use of Tamiflu in Infants Less than 1 Year of Age. http://bit.ly/TFL_1
  17. New Guidance Document, Dosage Delivery Devices for OTC Liquid Drug Products, published: http://bit.ly/4suOwR
  18. FDA Unveils Safe Use Initiative that Targets Preventable Harm from Medication Use, http://bit.ly/86LR0
  19. #Tamiflu: Consumer Questions and Answers, http://bit.ly/1afN7W
  20. #Relenza: Consumer Questions and Answers, http://bit.ly/45v5hW